Advantages of autologous blood transfusion in off-pump coronary artery bypass

Heart Surgery Forum

Volumn 12, Issue 5, 2009, Pages

  Ela, Yuksel ^a   Emmiler, Mustafa ^a   Kocogullari, Cevdet Ugur ^a   Terzi, Yuksel ^a   Sivaci, Remziye Gul ^a   Cekirdekci, Ahmet ^a  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; AUTACOID;

ADULT; ARTICLE; ATELECTASIS; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ERYTHROCYTE TRANSFUSION; EXTUBATION; FEMALE; FLUID RESUSCITATION; HEART ATRIUM FIBRILLATION; HUMAN; INTENSIVE CARE UNIT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OFF PUMP CORONARY SURGERY; PEROPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEDIMENTATION RATE; STERNOTOMY; SURGICAL PATIENT; TEMPERATURE; THORAX DRAINAGE; AGED; BLEEDING; BLOOD; COMPARATIVE STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEVER; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION;

AGED; BLOOD LOSS, SURGICAL; BLOOD SEDIMENTATION; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; C-REACTIVE PROTEIN; CORONARY ARTERY BYPASS, OFF-PUMP; FEMALE; FEVER; HUMANS; INFLAMMATION MEDIATORS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PULMONARY ATELECTASIS;

EID: 75349111430     PISSN: 10983511     EISSN: 15226662     Source Type: Journal    
DOI: 10.1532/HSF98.20081115     Document Type: Article

References (24)

1. Allain J-P, Akehurst RL, Hunter JM. 2002. Autologous transfusion, 3 years on: What is new? What has happened? Transfusion 39:910-1.
2. Aronson D, Boulos M, Suleiman A, et al. 2007. Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction. Am J Cardiol 100:753-7.
3. Ascione R, Williams S, Lloyd CT, Sundaramoorthi T, Pitsis AA, Angelini GD. 2001. Reduced postoperative blood loss and transfusion requirement after beating-heart coronary operations: a prospective randomized study. J Thorac Cardiovasc Surg 121:689-96.
4. Banbury MK, Brizzio ME, Rajeswaran J, Lytle BW, Blackstone EH. 2006. Transfusion increases the risk of postoperative infection after cardiovascular surgery. J Am Coll Surg 202:131-8.
5. Bryson GL, Laupacis A, Wells GA. 1998. Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion. Anesth Analg 86:9-15.
6. Casati V, Benussi S, Sandrelli L, Grasso MA, Spagnolo S. 2004. Intraoperative moderate acute normovolemic haemodilution associated with a comprehensive blood-sparing protocol in off-pump coronary surgery. Anesth Analg 98:1217-23.
7. Feng ZZ, Shi J, Zhao XW, Xu ZF. 2009. Meta-analysis of on-pump and off-pump coronary arterial revascularization. Ann Thorac Surg 87:757-65.
8. Goodnough LT. 1993. Blood conservation and blood transfusion practices: flip sides of the same coin. Ann Thorac Surg 56:3-4.
9. Gwozdziewicz M, Olsak P, Lonsky V, Elfmark M. 2008. The choice of on- or off-pump coronary bypass grafting: a surgeon's dilemma. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 152:289-92.
10. Jamnicki M, Kocian R, van der Linden P, Zaugg M, Spahn DR. 2003. Acute normovolemic haemodilution: physiology, limitations, and clinical use. J Cardiothorac Vasc Anesth 17:747-54.
11. Karamanoukian HL, Panos AL, Bergsland J, Salerno TA. 2000. Perspectives of a cardiac surgery resident in-training on off-pump coronary bypass operation. Ann Thorac Surg 69:42-5.
12. Mack MJ, Brown PP, Kugelmass AD, et al. 2004. Current status and outcomes of coronary revascularization 1999 to 2002: 148,396 surgical and percutaneous procedures. Ann Thorac Surg 77:761-6.
13. Matot I, Scheinin O, Jurim O, Eid A. 2002. Effectiveness of acute normovolemic haemodilution to minimize allogeneic blood transfusion in major liver resections. Anesthesiology 97:794-800.
14. Popovsky MA, Devine PA, Taswell HF. 1985. Intraoperative autologous transfusion. Mayo Clin Proc 60:125-34.
15. Puskas JD, Thourani VH, Marshall JJ, et al. 2001. Clinical outcomes, angiographic patency, and resource utilization in 200 consecutive off-pump coronary bypass patients. Ann Thorac Surg 71:1477-84.
16. Rastan AJ, Eckenstein JI, Hentschel B, et al. 2006. Emergency coronary artery bypass graft surgery for acute coronary syndrome: beating heart versus conventional cardioplegic cardiac arrest strategies. Circulation 114(suppl):I477-85.
17. Rittoo D, Gosling P, Simms MH, Smith SR, Vohra RK. 2005. The effects of hydroxyethyl starch compared with gelofusine on activated endothelium and the systemic inflammatory response following aortic aneurysm repair. Eur J Vasc Endovasc Surg 30:520-4.
18. Samolyk KA, Beckmann SR, Bissinger RC. 2005. A new practical technique to reduce allogeneic blood exposure and hospital costs while preserving clotting factors after cardiopulmonary bypass: the Hemobag. Perfusion 20:343-9.
19. Scott H, Seifert FC, Grimson R. 2008. Blood transfusion is associated with increased resource utilisation, morbidity and mortality in cardiac surgery. Ann Card Anaesth 11:15-9.
20. Segal JB, Blasco-Colmenares E, Norris EJ, Guallar E. 2004. Preoperative acute normovolemic hemodilution: a meta-analysis. Transfusion 44:632-44.
21. Staton GW, Williams WH, Mahoney EM, et al. 2005. Pulmonary outcomes of off-pump vs on-pump coronary artery bypass surgery in a randomized trial. Chest 127:892-901.
22. Stehling L, Zauder HL. 1991. Acute normovolemic haemodilution. Transfusion 31:857-68.
23. Treib J, Haass A, Pindur G, et al. 1995. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics. Thromb Haemost 74:1452-6.
24. Treib J, Haass A, Pindur G, Treib W, Wenzel E, Schimrigk K. 1996. Influence of intravascular molecular weight of hydroxyethyl starch on platelets. Eur J Haematol 56:168-72.